Researchers at UW-Madison have developed a way to detect prostate cancer by analyzing a prostate tissue sample for certain physical factors linked to the presence of cancer, according to the Wisconsin Alumni Research Foundation.

These changes, occurring in cancerous prostates “in regions away from the tumor sites,” have been found to be “statistically significantly different … between men with and without clinically significant cancer elsewhere in the prostate.”

The WARF site shows current clinical practice for prostate cancer screening uses a prostate specific antigen, or PSA, test.

Click here to read the full article.